Brinker Capital Investments’s Moderna MRNA Stock Holding History

Brinker Capital Investments’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$254K	Buy	+5,003	New	+$233K	﹤0.01%	1733
2024 Q4	–	Sell	-3,661	Closed	-$245K	–	1882
2024 Q3	$245K	Buy	3,661 +1,443	+65%	+$132K	﹤0.01%	1623
2024 Q2	$263K	Buy	+2,218	New	+$281K	﹤0.01%	1509
2024 Q1	–	Sell	-2,538	Closed	-$293K	–	1726
2023 Q4	$293K	Sell	2,538 -1,939	-43%	-$163K	﹤0.01%	1411
2023 Q3	$462K	Sell	4,477 -6,392	-59%	-$713K	0.01%	1229
2023 Q2	$1.32M	Buy	10,869 +583	+6%	+$77.8K	0.01%	830
2023 Q1	$1.58M	Buy	10,286 +1,757	+21%	+$290K	0.02%	691
2022 Q4	$1.53M	Buy	8,529 +1,956	+30%	+$320K	0.03%	580
2022 Q3	$777K	Buy	6,573 +3,666	+126%	+$556K	0.02%	800
2022 Q2	$415K	Buy	2,907 +1,238	+74%	+$177K	0.01%	1044
2022 Q1	$288K	Buy	1,669 +489	+41%	+$82.3K	﹤0.01%	1237
2021 Q4	$300K	Buy	+1,180	New	+$345K	﹤0.01%	1257

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brinker Capital Investments's MRNA Position: Q1 2026 in Review

Brinker Capital Investments opened a new position in Moderna (MRNA) in Q1 2026: 5,003 shares worth $254K. The stake represents ﹤0.01% of the portfolio and ranks #1733 among its holdings. This is a return to the name: Brinker Capital Investments previously reported a position in MRNA as recently as Q3 2024.

Brinker Capital Investments first reported a position in MRNA in Q4 2021 and has held it in 12 quarters since. The position peaked at $1.58M in Q1 2023. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Brinker Capital Investments held 5,003 shares of Moderna worth $254K as of Q1 2026.
Moderna was a new Brinker Capital Investments position in Q1 2026.
Moderna made up ﹤0.01% of Brinker Capital Investments's portfolio in Q1 2026, its #1733 holding.
Brinker Capital Investments first reported a position in Moderna in Q4 2021 and has held it in 12 quarters since.
Brinker Capital Investments's Moderna position peaked at $1.58M in Q1 2023.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.